Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge.&nbspClick  here to subscribe.

Study links anemia to increased risk of dying after a stroke

---

Male stroke survivors with severe anemia had a 3.5-times greater risk of dying while still in the hospital compared with surv&nbsp-More- 

ComprehensiveBMT&#8482: Complete BMT Center Data Management
Introducing the addition of ArchiveBMT&#8482 to the ComprehensiveBMT&#8482 suite of BMT Center data management. ArchiveBMT&#8482 incorporates historical data records into ComprehensiveBMT&#8482, making the data available for analyzing center-specific outcomes and trends over time. Register today for this free webinar on Feb. 22 at 2p EST, and see what ArchiveBMT&#8482 can do for your research.

Trial to use white blood cells to fight throat, lung cancer

---

A doctor in Boynton Beach, Fla., is running a clinical trial that will involve infusing a throat and lung cancer patient with&nbsp-More- 

Experimental blood test finds circulating tumor cells

---

Researchers at the Scripps Research Institute in La Jolla, Calif., have developed a blood test that can detect circulating tu&nbsp-More- 

Report: U.S. health data breaches hit \epidemic\ levels in 2011

---

A report from IT security evaluation firm Redspin finds the rate of U.S. &nbsp-More- 

Trial finds MultiStem technology can lower incidence of GvHD

---

A Phase I clinical trial involving patients with leukemia and similar blood diseases showed that Athersys MultiStem technolo&nbsp-More- 

Exosome, university get grant for blood-based diagnostic tests

---

The German Federal Ministry for Education and Research awarded Exosome Diagnostics and Ludwig Maximilian University a $1.3 mi&nbsp-More- 

Conflict-of-interest rules should remain unchanged, Hamburg says

---

There is no need for a legislative fix to conflict-of-interest restrictions on advisory panel members, FDA Commissioner Marga&nbsp-More- 

Trial is approved for stem cell treatment for dry AMD

---

The FDA is permitting StemCells to conduct a safety and efficacy trial of therapeutic candidate HuCNS-SC cells among patients&nbsp-More- 

AABB CT audioconference: Industry and Academic Collaborations -- Opportunities and Challenges

---

The Feb. &nbsp-More- 

Account Manager
Macopharma USA

Have no fear of perfection -- youll never reach it.

---

Salvador Dali,Spanish painter&nbsp-More-